Biomerieux Financial Statements From 2010 to 2025
| BIM Stock | EUR 114.60 0.70 0.61% |
Check Biomerieux financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biomerieux's main balance sheet or income statement drivers, such as , as well as many indicators such as . Biomerieux financial statements analysis is a perfect complement when working with Biomerieux Valuation or Volatility modules.
Biomerieux |
Biomerieux SA Company Operating Margin Analysis
Biomerieux's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Biomerieux Operating Margin | 0.21 % |
Most of Biomerieux's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biomerieux SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Biomerieux SA has an Operating Margin of 0.2145%. This is 100.61% lower than that of the Healthcare sector and 100.34% lower than that of the Diagnostics & Research industry. The operating margin for all France stocks is 103.89% lower than that of the firm.
Biomerieux SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biomerieux's current stock value. Our valuation model uses many indicators to compare Biomerieux value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biomerieux competition to find correlations between indicators driving Biomerieux's intrinsic value. More Info.Biomerieux SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.58 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Biomerieux SA is roughly 1.74 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biomerieux by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biomerieux's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Biomerieux Financial Statements
Biomerieux stakeholders use historical fundamental indicators, such as Biomerieux's revenue or net income, to determine how well the company is positioned to perform in the future. Although Biomerieux investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biomerieux's assets and liabilities are reflected in the revenues and expenses on Biomerieux's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biomerieux SA. Please read more on our technical analysis and fundamental analysis pages.
bioMrieux S.A. provides vitro diagnostic solutions systems for private and hospital laboratories, primarily for the diagnosis of infectious diseases. The company was formerly known as B-D Mrieux. bioMrieux S.A. was founded in 1963 and is based in Marcy lEtoile, France. bioMrieux S.A. is a subsidiary of Institut Mrieux SA. BIOMERIEUX operates under Diagnostics Research classification in France and is traded on Paris Stock Exchange. It employs 11200 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biomerieux Stock
Biomerieux financial ratios help investors to determine whether Biomerieux Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biomerieux with respect to the benefits of owning Biomerieux security.